Omalizumab therapy for mast cell-mediator symptoms in patients with ISM, CM, MMAS, and MCAS
The Journal of Allergy and Clinical Immunology: In Practice | May 09, 2019
Most read this week
The Journal of Allergy and Clinical Immunology: In Practice | May 09, 2019